SBIR Program Overview

  • August 19, 2020

A Crash Course on SBIR

Within the confines of the National Institute of Health (NIH) Small Business Innovation Research (SBIR) solicitations, there are three main categories to be on the lookout for- Phase I, Phase II, and Fast-Track. Each type of submission has its own rules, regulations, award amounts, and time frame. Recognizing the difference and deciding which one is the best fit for your project can save a lot of time and frustration.

SBIR Phase I Explained

A Phase I SBIR is intended to allow the testing of technical merit and feasibility of a proposed Research and Development (R&D) Project. The award is usually $150,000 and the allocated time frame is 6-12 months. No commercialization plan is needed for this type of submission. If your feasibility studies have already been completed, you can apply for a Direct Phase II, bypassing Phase I.

Phase II Explained

A Phase II SBIR is a full R&D award in the amount of $1,000,000 for two years. The purpose is to fine-tune and commercialize the technology. Phase II SBIR does require a commercialization plan. If your project will take more time and effort to test and develop, you could apply for a Phase IIB SBIR award, which offers 3 years. 

Fast Track

For those who like to live on the edge, there is also the Fast-Track option, where you will submit Phase I and Phase II applications together to be reviewed at once. Fast-Track awards can range from $150,000 to $1,000,000 and 2.5-3 years. Fast-Track requires you to follow all Phase I and Phase II regulations.

Keep up to date on SBIR changes here.

SBIR Proposal Preparation

Ready To Take the Next Step?

We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.